Actobio

Foundation date

2006

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

ActoBio Therapeutics™ is pioneering a new class of microbe-based healthcare agents: ActoBiotics® biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics.

Upcoming events

Latest news

  • iTeos Therapeutics Closes $125 Million Series B2 Financing

    Thursday April 2nd 2020

  • Mithra Announces Commercial Launch of Myring™ in Germany, the biggest market in Europe

    Thursday April 2nd 2020

  • Mithra Announces Donesta® Phase III Clinical Program Update

    Thursday April 2nd 2020